Oppenheimer Downgrades Corcept Therapeutics (CORT) to Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Oppenheimer Downgrades Corcept Therapeutics (CORT) to Perform

Corcept Therapeutics, Inc. (CORT) Tops Q3 EPS by 1c

October 31, 2012 4:51 PM EDT

Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.05 million versus the consensus estimate of $2.07 million.

For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.... More